In breast cancer, the transcription factor ZEB1 promotes macrophage glycolysis via the PI3K/Akt/HIF-1α pathway, facilitating their shift to a pro-tumor state and reinforcing immunosuppression within the TME (116). The gene discussed is HIF1A; the disease is neoplasm.